Here are relevant reports on : veterinary-telehealth-market
-
Veterinary Ophthalmology Equipment Market by Product (Ophthalmoscope, Retinoscope, Fundus Camera, Slit Lamp), Animal Type (Canine, Feline, Livestock), Application (Treatment, Surgery, Diagnosis, Monitoring), End User, Region - Global Forecast to 2031
The global Veterinary Ophthalmology Equipment market, valued at USD 0.54 billion in 2025, stood at USD 0.57 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of USD 0.83 billion by the end of the period. Growth in the demand for early and precise diagnosis of ocular disorders among companion animals, rising adoption of advanced ophthalmic technologies such as digital slit lamps, optical coherence tomography (OCT), electroretinography (ERG), and tonometry systems, and growing focus on routine and preventive eye health examination of pets are some of the key factors driving this market.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Pharmaceuticals Market by Product (Drugs, mAbs, Immunomodulators, Medicated Feed Additives), Route of Administration, Formulation Type, Indication, Animal Type (Companion, Livestock), Distribution Channel, End User—Global Forecast to 2031
The global veterinary pharmaceuticals market, valued at USD 27.41 billion in 2025, stood at USD 28.98 billion in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 39.37 billion by the end of the period. The market growth is driven by rising pet ownership, increasing livestock production, and higher demand for disease management drugs. Expanding awareness of animal health, growing expenditure on companion animals, and advancements in anti-infectives, parasiticides, and dermatology treatments are further supporting steady market expansion across developed and emerging regions.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Companion Animal Pharmaceuticals Market by Animal Type (Dogs, Cats, Horses), Route of Administration (Oral, Injectable, Topical), Indication (Antibiotics, Parasiticides), Distribution Channel (Veterinary Hospitals & Clinics) & Region - Global Forecasts to 2027
The global companion animal pharmaceuticals market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. Major players operating in the market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Veterinary Monoclonal Antibodies Market by Animal Type (Canine, Feline, Swine), Product (Cytopoint, Librela, Solensia), Therapy Area (Dermatology, Infectious, Osteoarthritis, Pain, Oncology, Others), Route of Administration - Global Forecast to 2030
The global veterinary monoclonal antibodies market, valued at US$1.52 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.06 billion by the end of the period. Opportunities in the market involve expanding therapeutic uses beyond dermatology and osteoarthritis, as well as developing new administration routes for monoclonal antibodies.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030
The global veterinary reference laboratory market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$6.45 billion by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Animal Parasiticides Market by Type (Ectoparasiticides, Endoparasiticides, Endectocides), Animal Type (Dogs, Cats, Horses, Cattle, Pigs, Poultry), End User (Veterinary Hospitals, Animal Farms, Home Care Settings), & Region - Global Forecast to 2031
The global animal parasiticides market, valued at USD 12.30 billion in 2025, stood at USD 12.98 billion in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of USD 17.50 billion by the end of the period. The major factors contributing to this growth are increased expenditure on pet healthcare, the rising awareness of the need for parasite prevention throughout the year, and the strong market receptivity to novel, easy-to-administer treatment solutions.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Gene Amplification Technology Market by Technology (Target Amplification, Signal Amplification, Isothermal DNA Amplification), Applicatiion (Medical, Forensics, Paternity, Food Safety, Agri-Diagnostics, Veterinary) - Analysis & Global Forecast to 2019
Gene amplification technology is one of the most important technologies used in genomic projects and plays vital role in other application areas such as diagnostics. There are large number of gene- and signal-amplification technologies, from polymerase chain reaction to ligase chain reaction, transcription mediated amplification, and dendritic polymers. These technologies are widely used in various applications in research and clinical settings.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Services Market by Service Type (Diagnostic Tests & Imaging, Surgery, Physical Health Monitoring, Vaccination), Animal Type (Food-producing, Companion), Delivery Channel (Hospitals & Clinics, Commercial facilities), and Region - Global Forecast to 2027
The global veterinary services market size is projected to reach USD 139.2 billion by 2027 from USD 100 billion in 2022, at a CAGR of xx% during the forecast period. Market is driven by factors such as growing awareness for pet health, Increasing prevalence of various diseases in animals or zoonotic diseases, and rising demand for effective medical care. On the other hand, high cost of veterinary services and shortage of skilled personnel is expected to limit market growth to a certain extent in the coming years.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030
The global lateral flow assay components market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is projected to advance at a resilient CAGR of 4.4% from 2025 to 2030, culminating in a forecasted valuation of US$486.2 million by the end of the period. Market growth is driven by increasing health awareness and the shift toward lifestyle and home-based healthcare, as more consumers adopt self-monitoring and rapid testing solutions.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Meat Testing Market by Target Tested (Pathogen, Species, Allergen, GMO, Mycotoxin, Heavy Metal, Veterinary Drug Residue), Sample (Meat and Seafood), Technology (PCR, Immunoassay, Chromatography, Spectroscopy), and Region - Global Forecast to 2023
The global meat testing market is projected to grow at a CAGR of 7.7%, to reach USD 11.48 billion by 2023. Outbreaks of diseases due to contaminated meat & seafood have massively transformed the industry, leading to increased government regulations on meat products and their quality. Increasing incidents of such frauds are a major concern in the industry. These factors are the major drivers of the meat testing industry, globally. This report includes a study of marketing and development strategies, along with the product portfolios of the leading companies. It includes profiles of leading companies such as SGS (Switzerland), Eurofins (Luxemburg), Bureau Veritas (France), Intertek (UK), TUV SUD (Germany), ALS (Australia), Mérieux NutriSciences (US), AsureQuality (New Zealand), Romer Labs (Austria), LGC Limited (UK), Genetic ID (US), and Microbac Laboratories (US).
- Published: June 2018
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
